PLA2G7 and neoplasm: Interestingly, pre‐cachectic C26 tumour‐bearing mice exhibited intermediate activity levels, between non‐cachectic PBS‐injected and cachectic C26 tumour‐bearing mice (Figure1I), showing that circulating PLA2G7 progressively rises with cachexia development.